---
figid: PMC6661033__12072_2019_9960_Fig7_HTML
figlink: /pmc/articles/PMC6661033/figure/Fig7/
number: Fig. 7
caption: The upregulation of CCN2 are closely related to oxaliplatin treatment in
  HCC, and CCN2 interacting with many cell membrane receptors such as LRP6, Met, integrins,
  etc., significantly enhanced oxaliplatin resistance by activating the MAPK/Id-1
  signaling pathway. Id-1 upregulate CCN2 in a positive feedback manner, and sorafenib
  or U0126 could significantly inhibit Id-1 expression by blocking the CCN2–MAPK–Id-1
  loop
pmcid: PMC6661033
papertitle: CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining
  stemness in oxaliplatin-resistant hepatocellular carcinoma.
reftext: Xia Liao, et al. Hepatol Int. 2019 Jul;13(4):440-453.
pmc_ranked_result_index: '84275'
pathway_score: 0.9718708
filename: 12072_2019_9960_Fig7_HTML.jpg
figtitle: CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness
  in oxaliplatin-resistant hepatocellular carcinoma.
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6661033__12072_2019_9960_Fig7_HTML.html
  '@type': Dataset
  description: The upregulation of CCN2 are closely related to oxaliplatin treatment
    in HCC, and CCN2 interacting with many cell membrane receptors such as LRP6, Met,
    integrins, etc., significantly enhanced oxaliplatin resistance by activating the
    MAPK/Id-1 signaling pathway. Id-1 upregulate CCN2 in a positive feedback manner,
    and sorafenib or U0126 could significantly inhibit Id-1 expression by blocking
    the CCN2–MAPK–Id-1 loop
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CTGF
  - MAPK3
  - ID1
  - RAF1
  - ARAF
  - MAP2K1
  - MAPK1
  - KRAS
  - NRAS
  - MAP2K2
  - BRAF
  - HRAS
  - Oxaliplatin
  - Sorafenib
  - U0126
genes:
- word: CCN2
  symbol: CCN2
  source: hgnc_alias_symbol
  hgnc_symbol: CTGF
  entrez: '1490'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Id-1
  symbol: ID1
  source: hgnc_symbol
  hgnc_symbol: ID1
  entrez: '3397'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
chemicals:
- word: Oxaliplatin
  source: MESH
  identifier: C030110
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: U0126
  source: MESH
  identifier: C113580
diseases: []
---
